Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2025 ended March 31, 2025, after the market closes on Wednesday, May 7th, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.
To access the conference call, dial toll free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.
The call can also be accessed on the Investors page on the Company's website www.amphastar.com. The webcast replay of the call will be available on our Company website within 24 hours after the end of the live conference call.
Company Information
Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company's finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. More information and resources are available at www.amphastar.com.
Forward Looking Statements
All statements in this press release and in the conference call referenced above that are not historical are forward-looking statements, including, among other things, statements relating to our expectations regarding future financial performance and business trends, our future growth, sales and marketing of our products, market size and expansion, product portfolio, product development, the timing of FDA filings or approvals, including the DMFs of ANP, the timing of product launches, acquisitions and other matters related to our pipeline of product candidates, the timing and results of clinical trials, the benefits BAQSIMI®, including its potential for continued revenue growth, the strategic trajectory of and market for our product pipeline, our ability to leverage our existing expertise and technology, and other future events. These statements are not facts but rather are based on Amphastar's historical performance and our current expectations, estimates, and projections regarding our business, operations, and other similar or related factors. Words such as 'may,' 'might,' 'will,' 'could,' 'would,' 'should,' 'anticipate,' 'predict,' 'potential,' 'continue,' 'expect,' 'intend,' 'plan,' 'project,' 'believe,' 'estimate,' and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Amphastar's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Amphastar's filings with the Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 3, 2025 and our other filings or reports that we may file with the SEC. In particular, there can be no guarantee that our sales strategies will be successful, or that we will continue to experience significant sales of BAQSIMI®. You can locate these reports through our website at http://ir.amphastar.com and on the SEC's website at www.sec.gov. The forward-looking statements in this release speak only as of the date of the release. Amphastar undertakes no obligation to revise or update information or any forward-looking statements in this press release or the conference call referenced above to reflect events or circumstances in the future, even if new information becomes available or if subsequent events cause our expectations to change.
Contact:
Bill Peters
Chief Financial Officer
(909) 476-3416
SOURCE: Amphastar Pharmaceuticals, Inc.
press release
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Pennsylvania Treasury returns nearly $30 million in unclaimed property in May
(WHTM) — The Pennsylvania Treasury announced it returned nearly $30 million in unclaimed property to rightful owners in May. According to the Pennsylvania Treasury, approximately $28 million in unclaimed property was returned to Pennsylvanians in May 2025. 'Treasury receives hundreds of millions of dollars in unclaimed property every year, often because of something as simple as a misspelled name or an out-of-date address. But let's be clear: this is YOUR money we're talking about, and I want to return it to you,' Pennsylvania Treasurer Stacy Garrity said. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now The treasury says one in 10 Pennsylvanians has unclaimed property, with the average claim being around $1,600. Pennsylvanians can check to see if they have property available to be claimed online. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
33 minutes ago
- Yahoo
KeyBanc Initiates Coverage of Zoom Communications (ZM) With Underweight Rating
Zoom Communications Inc. (NASDAQ:ZM) is one of the 10 tech stocks on Wall Street's radar right now. On June 6, KeyBanc initiated coverage of Zoom Communications Inc. (NASDAQ:ZM) with an Underweight rating and set a $73 price target in a broader report on select Enterprise Software companies. The analyst noted that the company's core video conferencing business has faced challenges since the pandemic peak, as in-person work returned. The firm also mentioned the competitive pressure from Microsoft as it has strengthened its position with Teams, improving features and user experience. Keybanc said that the company's efforts to grow beyond video collaboration have not been very compelling. A close-up of a hand using a laptop to control an immersive video meeting. Similarly, on May 22, Wells Fargo increased its price target on Zoom Communications Inc. (NASDAQ:ZM) from $75 to $80 and maintained an Equal Weight rating on the stock. The stock was already trading around $2 above the analyst's price target on the day. Zoom (NASDAQ:ZM) provides an AI-driven work platform featuring video meetings, messaging, cloud phone systems, and productivity tools like whiteboards, workflow automation, and modular docs, while also supporting virtual events, contact centers, and third-party app integration across various industries. While we acknowledge the potential of ZM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
B.Riley Raises Price Target on Silicon Motion (SIMO), Maintains Buy Rating
Silicon Motion Technology Corporation (NASDAQ:SIMO) is one of the . On June 5, increased its price target on Silicon Motion Technology Corporation (NASDAQ:SIMO) to $90 from $75 and reaffirmed its Buy rating on the stock. The firm pointed to the expanded Nvidia Bluefield DPU win and the upcoming Nintendo Switch 2 cycle as drivers of longer-term gains for the company. It further added that progress in the PCIe Gen5 PC and notebook market is on track, with Silicon Motion (NASDAQ:SIMO) projected to grow its market share to over 50% using its 8- and 4-channel products. Additionally, provided a bullish outlook on the company's future earnings as it said that similar momentum is expected from the adoption of UFS 4.0 in smartphones. The developments could push estimated earnings per share in 2026 and 2027 to around $5.25 and $6.50, respectively. An engineer in a lab coat tweaking a circuit board with intricate semiconductors. During the company's Q1 2025 earnings call, management highlighted that Silicon Motion (NASDAQ:SIMO) has partnered with NVIDIA for over a year to qualify its MonTitan server boot storage for the BlueField-3 DPU, a platform designed to optimize AI workloads and cloud networking. Starting later this year, its boot storage will support BlueField-3, creating new revenue and growth opportunities. Silicon Motion (NASDAQ:SIMO) designs and sells NAND flash controllers and specialized SSDs for various applications, including computing, enterprise data centers, mobile devices, and industrial uses, under multiple brand names. While we acknowledge the potential of SIMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
